GSK, Valeant Dodge Sham Patent Suit Claims In Wellbutrin Row
A Pennsylvania federal judge on Friday granted a move by GlaxoSmithKline PLC and Valeant Pharmaceuticals International to toss claims brought by purchasers of depression medication Wellbutrin XL in an antitrust class...To view the full article, register now.
Already a subscriber? Click here to view full article